Operose Advisors’s CME Group CME Stock Holding History

Operose Advisors’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-143	Closed	-$42.2K	–	544
2026 Q1	$42.2K	Buy	+143	New	+$42.5K	0.01%	304
2025 Q1	–	Sell	-10	Closed	-$2.32K	–	404
2024 Q4	$2.32K	Sell	10 -140	-93%	-$32.2K	﹤0.01%	390
2024 Q3	$33.1K	Hold	150	–	–	0.01%	326
2024 Q2	$29.5K	Hold	150	–	–	0.01%	302
2024 Q1	$32.3K	Sell	150 -45	-23%	-$9.45K	0.01%	305
2023 Q4	$41.1K	Sell	195 -187	-49%	-$39.9K	0.02%	242
2023 Q3	$76.5K	Buy	382 +337	+749%	+$67K	0.03%	242
2023 Q2	$8.34K	Hold	45	–	–	﹤0.01%	288
2023 Q1	$8.62K	Hold	45	–	–	﹤0.01%	272
2022 Q4	$7.57K	Hold	45	–	–	﹤0.01%	301
2022 Q3	$8K	Hold	45	–	–	0.01%	280
2022 Q2	$9K	Hold	45	–	–	0.01%	243
2022 Q1	$11K	Hold	45	–	–	0.01%	258
2021 Q4	$10K	Buy	+45	New	+$9.9K	0.01%	255

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Operose Advisors's CME Position: Q2 2026 in Review

Operose Advisors sold out of CME Group (CME) in Q2 2026, closing a stake of 143 shares — an estimated $42.2K sold.

Operose Advisors first reported a position in CME in Q4 2021 and held it in 14 quarters. The position peaked at $76.5K in Q3 2023. 1,701 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Operose Advisors reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
Operose Advisors sold 143 CME Group shares in Q2 2026, an estimated $42.2K.
Operose Advisors first reported a position in CME Group in Q4 2021 and held it in 14 quarters.
Operose Advisors's CME Group position peaked at $76.5K in Q3 2023.
1,701 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Operose Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.